In contrast, semaglutide GLP-1 is marketed under the brand name Wegovy when it is specifically intended for weight management
These areas are specifically chosen because they contain adequate subcutaneous fatty tissue, which allows for proper absorption of the medication into the bloodstream
GI side effects A recent systematic review of 39 randomized controlled trials of GLP-1RAs showed a class effect of increased risks of nausea, vomiting, diarrhea and constipation compared with placebo (15) in individuals without diabetes
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 19902019: a systematic analysis for the global burden of disease study 2019
2 CASE PRESENTATIONS Case 1 A 75-year-old woman with a history of type II diabetes presented with an itchy rash on her legs, back, and chest for 3 months duration